Chronic pancreatitis: current status and challenges for prevention and treatment
PDF (Русский)
DOCX (Українська)


chronic pancreatitis, acute recurrent pancreatitis, hereditary pancreatitis, cystic fibrosis, alcohol, smoking

How to Cite

Lew, D., Afghani, E., & Pandol, S. (2020). Chronic pancreatitis: current status and challenges for prevention and treatment. Herald of Pancreatic Club, 47(2), 6-18.

Abstract views: 76
PDF Downloads: 21 PDF Downloads: 0


This article presents the results of modern epidemiological studies that emphasize the increasing prevalence of acute and chronic pancreatitis (CP) in many countries, as well as the high likelihood of developing secondary diabetes mellitus, pancreatic cancer. The risk factors for CP occurrence are listed, such as: alcohol, smoking, genetic predisposition, anatomical and obstructive disorders; pathogenetic mechanisms of CP development in the outcome of acute pancreatitis are considered. Attention is paid to laboratory instrumental diagnosis of CP, the advantages and disadvantages of transabdominal ultrasound, computed tomography and magnetic resonance imaging. The emphasis is made on the use of endoscopic ultrasound, diagnostic tests to evaluate exocrine pancreatic function (fecal elastase-1, trypsinogen, triglyceride breath test, cholecystokinin test). The role of correction of modifiable factors and the rejection of bad habits in the treatment of CP is noted. Modern pharmacotherapy regimens for CP with analgesics (starting with non-steroidal anti-inflammatory drugs), tricyclic antidepressants, pregabalin, enzyme replacement therapy, simvastatin are described. Surgical techniques for pain relief in CP (endoscopic decompression, shock wave lithotripsy, resection) are considered. The therapeutic techniques for preventing CP complications are described, and the expediency of conducting prolonged enzyme replacement therapy is emphasized. The problematic aspects of pancreatology are listed that need to be studied in future in order to improve outcomes and prognosis in patients with CP.
PDF (Русский)
DOCX (Українська)


Adler D. G., Lichtenstein D., Baron T. H et al. The role of endoscopy in patients with chronic pancreatitis. Gastrointest. Endosc. 2006. Vol. 63. P. 933–937.

Ahmed Ali U., Jens S., Busch O. R. et al. Antioxidants for pain in chronic pancreatitis. Cochrane Database Syst. Rev. 2014. Vol. (8):CD008945.

Albashir S., Bronner M. P., Parsi M. A., Walsh R. M., Stevens T. Endoscopic ultrasound, secretin endoscopic pancreatic function test, and histology: correlation in chronic pancreatitis. Am. J. Gastroenterol. 2010. Vol. 105. P. 2498–2503.

Alpern M. B., Sandler M. A., Kellman G. M. et al. Chronic pancreatitis: ultrasonic features. Radiology. 1985. Vol. 155. Р. 215–219.

Amann S. T., Bishop M., Curington C., Toskes P. P. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas. 1996. Vol. 13. P. 226–230.

Ammann R. W. Alcohol and non-alcohol induced pancreatitis: clinical aspects (chapter 16). In: Burns G. P., Bank S., eds. Disorders of the pancreas: current issues in diagnosis and management. Philadelphia: McGraw Hill. Vol. 1992. P. 253–271.

Ammann R. W., Akovbiantz A., Largiader F., Schueler G. Course and outcome of chronic pancreatitis: longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology. 1984. Vol. 86. P. 820–828.

Andersen D. K., Andren-Sandberg A., Duell E. J. et al. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas. 2013. Vol. 42. P. 1227–1237.

Andriulli A., Botteri E., Almasio P. L., Vantini I., Uomo G., Maisonneuve P. For the ad hoc committee of the Italian Association for the study of the pancreas. Smoking as a cofactor for causation of chronic pancreatitis: a meta-analysis. Pancreas. 2010. Vol. 39. P. 1205–1210.

Apte M. V., Haber P. S., Darby S. J. et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999. Vol. 44. P. 534–541.

Apte M. V., Phillips P. A., Fahmy R. G. et al. Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology. 2000. Vol. 118. P. 780–794.

Apte M. V., Pirola R. C., Wilson J. S. Pancreatic stellate cells: a starring role in normal and diseased pancreas. Front Physiol. 2012. Vol. 3. P. 344.

Axon A. T., Classen M., Cotton P. B. et al. Pancreatography in chronic pancreatitis: international definitions. Gut. 1984. Vol. 25. P. 1107–1112.

Balaji L. N., Tandon R. K., Tandon B. N. et al. Prevalence and clinical features of chronic pancreatitis in southern India. Int. J. Pancreatol. 1994. Vol. 15. P. 29–34.

Balci N. C., Alkaade S., Magas L., Momtahen A. J., Burton F. R. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP. J. Magn. Reson. Imaging. 2008. Vol. 27. P. 125–131.

Bellin M. D., Freeman M. L. Gelrud A. et al. Total pancreatectomy and islet auto transplantation in chronic pancreatitis: recommendations from PancreasFest. Pancreatology. 2014. Vol. 14. P. 27–35.

Bertin C., Pelletier A. L., Vullierme M. P. et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am. J. Gastroenterol. 2012. Vol. 107. P. 311–317.

Bhutani M. S., Arantes V. N., Verma D. et al. Histopathologic correlation of endoscopic ultrasound findings of chronic pancreatitis in human autopsies. Pancreas. 2009. Vol. 38. P. 820–824.

Blinman T. A., Gukovsky I., Mouria M. etal. Activation of pancreatic acinar cells on isolation from tissue: cytokine upregulation via p38 MAP kinase. Am. J. Physiol. Cell Physiol. 2000. Vol. 279. P. C1993–C2003.

Bo-linn G. W., Fordtran J. S. Fecal fat concentration in patients with steatorrhea. Gastroenterology. 1984. Vol. 87. P. 319–322.

Bouwense S. A., Olesen S. S, Drewes A. M. et al. Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized, controlled trial. PLoS One. 2012. Vol. 7. P. e42096.

Braden B. (13)C breath tests for the assessment of exocrine pancreatic function. Pancreas. 2010. Vol. 39. P. 955–959.

Braganza J. M. Pancreatic disease: a casualty of hepatic ‘detoxification’? Lancet. 1983. Vol. 2. P. 1000–1002.

Brown A., Hughes M., Tenner S., Banks P. A. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am. J. Gastroenterol. 1997. Vol. 92. P. 2032–2035.

Cahen D. L., Gouma D. J., Laramée P. et al. Long-term outcomes of endoscopic vs surgical drainage of the pancreatic duct in patients with chronic pancreatitis. Gastroenterology. 2011. Vol. 141. P. 1690–1695.

Chantarojanasiri T., Hirooka Y., Ratanachu-Ek T., Kawashima H., Ohno E., Goto H. Evolution of pancreas in aging: degenerative variation or early changes of disease? J. Med. Ultrason. 2001. Vol. 2015. P. 177–183.

Chong A. K., Hawes R. H., Hoffman B. J., Adams D. B., Lewin D. N., Romagnuolo J. Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest. Endosc. 2007. Vol. 65. P. 808–814.

Chowdhury R. S., Forsmark C. E. Review article: pancreatic function testing. Aliment. Pharmacol. Ther. 2003. Vol. 17. P. 733–750.

Comfort H. W., Gambill E. E., Baggenstoss A. H. Chronic relapsing pancreatitis: a study of 29 cases without associated disease of the biliary or gastrointestinal tract. Gastroenterology. 1946. Vol. 6. P. 239–285.

Comfort M. W., Steinberg A. G. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology. 1952. Vol. 21. P. 54–63.

Conwell D. L., Lee L. S., Yadav D. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014. Vol. 43. P. 1143–1162.

Corrao G., Bagnardi V., Zambon A., Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction. 1999. Vol. 94. P. 1551–1573.

De-Madaria E., Abad-Gonzalez A., Aparicio J. R. et al. The Spanish Pancreatic Club’s recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). Pancreatology. 2013. Vol. 13. P. 18–28.

Demir I. E., Friess H., Ceyhan G. O. Neural plasticity in pancreatitis and pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 2015. Vol. 12. P. 649–659.

DiMagno E. P., Go V. L., Summerskill W. H. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N. Engl. J. Med. 1973. Vol. 288. P. 813–815.

Dumonceau J. M., Deviere J., Le M. O. et al. Endoscopic pancreatic drainage in chronic pancreatitis associated with ductal stones: long-term results. Gastrointest. Endosc. 1996. Vol. 43. P. 547–555.

Gabbrielli A., Pandolfi M., Mutignani M. et al. Efficacy of main pancreatic-duct endoscopic drainage in patients with chronic pancreatitis, continuous pain, and dilated duct. Gastrointest. Endosc. 2005. Vol. 61. P. 576–581.

Gilron I., Bailey J. M., Tu D., Holden R. R., Jackson A. C., Houlden R. L. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet. 2009. Vol. 374. P. 1252–1261.

Goulden M. R. The pain of chronic pancreatitis: a persistent clinical challenge. Br. J. Pain. 2013. Vol. 7. P. 8–22.

Guda N. M., Partington S., Freeman M. L. Extracorporeal shock wave lithotripsy in the management of chronic calcific pancreatitis: a meta-analysis. JOP. 2005. Vol. 6. P. 6–12.

Gudipaty L., Rickels M. R. Pancreatogenic (Type 3c) Diabetes. 2015

Gukovsky I., Gukovskaya A. S., Blinman T. A., Zaninovic V., Pandol S. J. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am. J. Physiol. 1998. Vol. 275. Р. G1402–G1414.

Gukovsky I., Li N., Todoric J., Gukovskaya A., Karin M. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology. 2013. Vol. 144. P. 1199–1209.

Gullo L., Ventrucci M., Tomassetti P., Migliori M., Pezzilli R. Fecal elastase 1 determination in chronic pancreatitis. Dig. Dis. Sci. 1999. Vol. 44. P. 210–213.

Gyr K., Agrawal N. M., Felsenfeld O., Font R. G. Comparative study of secretin and Lundh tests. Am. J. Dig. Dis. 1975. Vol. 20. P. 506–512.

Habtezion A. Inflammation in acute and chronic pancreatitis. Curr. Opin. Gastroenterol. 2015. Vol. 31. P. 395–399.

Hart P. A., Topazian M., Raimondo M. et al. Endoscopic pancreas fluid collection: methods and relevance for clinical care and translational science. Am. J. Gastroenterol. 2016. Vol. 111. P. 1258–1266.

Hastier P., Buckley M. J., Francois E. et al. A prospective study of pancreatic disease in patients with alcoholic cirrhosis: comparative diagnostic value of ERCP and EUS and long-term significance of isolated parenchymal abnormalities. Gastrointest. Endosc. 1999. Vol. 49. P. 705–709.

Hegyi P., Pandol S., Venglovecz V., Rakonczay Z. The acinarductal tango in the pathogenesis of acute pancreatitis. Gut. 2011. Vol. 60. P. 544–552.

Howes N., Lerch M. M., Greenhalf W. et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol. 2004. Vol. 2. P. 252–261.

Iglesias-Garcia J., Dommguez-Munoz J. E., Castineira-Alvarino M., Luaces-Regueira M., Larino-Noia J. Quantitative elastography associated with endoscopic ultrasound for the diagnosis of chronic pancreatitis. Endoscopy. 2013. Vol. 45. P. 781–788.

Irving H. M., Samokhvalov A. V., Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009. Vol. 10. P. 387–392.

Isaksson G., Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig. Dis. Sci. 1983. Vol. 28. P. 97, e102.

Itoh Y., Itoh A., Kawashima H. et al. Quantitative analysis of diagnosing pancreatic fibrosis using EUS-elastography (comparison with surgical specimens). J. Gastroenterol. 2014. Vol. 49. P. 1183–1192.

Jacobson D. G., Curington C., Connery K., Toskes P. P. Trypsin-like immunoreactivity as a test for pancreatic insufficiency. N Engl. J. Med. 1984. Vol. 310. P. 1307–1309.

Janssen J., Schlorer E., Greiner L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest. Endosc. 2007. Vol. 65. P. 971–978.

Ketwaroo G., Brown A., Young B. et al. Defining the accuracy of secretin pancreatic function testing in patients with suspected early chronic pancreatitis. Am. J. Gastroenterol. 2013. Vol. 108. P. 1360-1366.

Kloppel G., Maillet B. Chronic pancreatitis: evolution of the disease. Hepatogastroenterol. 1991. Vol. 38. P. 408–412.

Kloppel G., Maillet B. The morphological basis for the evolution of acute pancreatitis into chronic pancreatitis. Virchows. Arch. A Pathol. Anat. Histopathol. 1992. Vol. 420. P. 1–4.

Lankisch P. G., Breuer N., Bruns A. et al. Natural history of acute pancreatitis: a long-term population based study. Am. J. Gastroenterol. 2009. Vol. 104. P. 2797–2805. quiz 2806.

Lankisch P. G., Lohr-Happe A., Otto J., Creutzfeldt W. Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion. 1993. Vol. 54. P. 148–155.

Laterza L., Scaldaferri F., Bruno G. etal. Pancreatic function assessment. Eur. Rev. Med. Pharmacol. Sci. 2013. Vol. 17. P. 65–71.

Layer P., Yamamoto H., Kalthoff L. et al. The different courses of early and late onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology. 1994. Vol. 107. P. 1481–1487.

LeBlanc J. K., Chen J. H., Al-Haddad M. et al. Endoscopic ultrasound and histology in chronic pancreatitis: how are they associated? Pancreas. 2014. Vol. 43. P. 440–444.

Lieb J. G. II, Draganov P. V. Pancreatic function testing: here to stay for the 21st century. World J. Gastroenterol. 2008. Vol. 14. P. 3149–3158.

Loser C., Brauer C., Aygen S., Hennemann O., Folsch U. R. Comparative clinical evaluation of the 13C mixed triglyceride breath test as an indirect pancreatic function test. Scand. J. Gastroenterol. 1998. Vol. 33. P. 327–334.

Lowenfels A. B., Maisonneuve P., Grover H. et al. Racial factors and the risk of chronic pancreatitis. Am. J. Gastroenterol. 1999. Vol. 94. P. 790–794.

Luetmer P. H., Stephens D. H., Ward E. M. Chronic pancreatitis: reassessment with current CT. Radiology. 1989. Vol. 171. P. 353–357.

Lugea A., Tischler D., Nguyen J. et al. Adaptive unfolded protein response attenuates alcohol-induced pancreatic damage. Gastroenterology. 2011. Vol. 140. P. 987–997.

Lugea A., Waldron R. T., Pandol S. J. Pancreatic adaptive responses in alcohol abuse: role of the unfolded protein response. Pancreatology. 2015. Vol. 15. P. S1–S5.

Maleth J., Balazs A., Pallagi P. et al. Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis. Gastroenterology. 2015. Vol. 148. P. 27–439.

Malka D., Hammel P., Sauvanet A. et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 2000. Vol. 119. P. 1324–1332.

Manjari K. S., Jyothy A., Vidyasagar A., Prabhakar B., Nallari P., Venkateshwari A. Matrix metalloproteinase-9, transforming growth factor-p1, and tumor necrosis factor-a plasma levels in chronic pancreatitis. Indian J. Gastroenterol. 2013. Vol. 32. P. 103–107.

Mergener K., Baillie J. Chronic pancreatitis. Lancet. 1997. Vol. 350. P. 1379–1385.

Michaels A. J., Draganov P. V. Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis. World J. Gastroenterol. 2007. Vol. 13. P. 3575–3580.

Mohan V., Farooq S., Deepa M. Prevalence of fibrocalculous pancreatic diabetes in Chennai in South India. JOP. 2008. Vol. 9. P. 489–492.

Morris-stiff G., Webster P., Frost B., Lewis W. G., Puntis M. C., Roberts S. A. Endoscopic ultrasound reliably identifies chronic pancreatitis when other imaging modalities have been non-diagnostic. JOP. 2009. Vol. 10. P. 280–283.

Nojgaard C., Becker U., Matzen P., Andersen J. R., Holst C., Bendtsen F. Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course. Pancreas. 2011. Vol. 40. P. 1195–1200.

Olesen S. S., Bouwense S. A., Wilder-Smith O. H., Van Goor H., Drewes A. M. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology. 2011. Vol. 141. P. 536–543.

Omary M. B., Lugea A., Lowe A. W., Pandol S. J. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J. Clin. Invest. 2007. Vol. 117. P. 50–59.

Pandol S. J., Gorelick F. S., Lugea A. Environmental and genetic stressors and the unfolded protein response in exocrine pancreatic function — a hypothesis. Front. Physiol. 2011. Vol. 2. P. 8.

Pandol S. J., Periskic S., Gukovsky I. et al. Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology. 1999. Vol. 117. P. 706–716.

Peery A. F., Crockett S. D., Barritt A. S. et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015. Vol. 149. P. 1731–1741.

Perrault J. Hereditary pancreatitis. Gastroenterol. Clin. North Am. 1994. Vol. 23. P. 743–752.

Raimondi S., Lowenfels A. B., Morselli-Labate A. M., Maisonneuve P., Pezzilli R. Pancreatic cancer in chronic pancreatitis. Vol. Aetiology, incidence, and early detection. Best Pract. Res. Clin. Gastroenterol. 2010. Vol. 24. P. 349–358.

Rajan E., Clain J. E., Levy M. J. et al. Age-related changes in the pancreas identified by EUS: a prospective evaluation. Gastrointest. Endosc. 2005. Vol. 61. P. 401–406.

Rasmussen H. H., Irtun O., Olesen S. S., Drewes A. M., Holst M. Nutrition in chronic pancreatitis. World J. Gastroenterol. 2013. Vol. 19. P. 7267–7275.

Rösch T., Daniel S., Scholz M. et al. Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy. 2002. Vol. 34. P. 765–771.

Rosendahl J., Witt H., Szmola R. et al. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat. Genet. 2008. Vol. 40. P. 78–82.

Samokhvalov A. V., Rehm J., Roerecke M. Alcohol consumption as a risk factor for acute and chronic pancreatitis: a systematic review and a series of meta-analyses. EBioMedicine. 2015. Vol. 2. P. 1996–2002.

Santosh D., Lakhtakia S., Gupta R. et al. Clinical trial: a randomized trial comparing fluoroscopy guided percutaneous technique vs. endoscopic ultrasound guided technique of coeliac plexus block for treatment of pain in chronic pancreatitis. Aliment. Pharmacol. Ther. 2009. Vol. 29. P. 979–984.

Schneider A., Barmada M. M., Slivka A., Martin J. A., Whitcomb D. C. Clinical characterization of patients with idiopathic chronic pancreatitis and SPINK1 Mutations. Scand. J. Gastroenterol. 2004. Vol. 39. P. 903–904.

Schneider A., Whitcomb D. C. Hereditary pancreatitis: a model for inflammatory diseases of the pancreas. Best Pract. Res. Clin. Gastroenterol. 2002. Vol. 16. P. 347–363.

Setiawan V. W., Pandol S. J., Porcel J. et al. Prospective study of alcohol drinking, smoking, and pancreatitis: the multiethnic cohort. Pancreas. 2016. Vol. 45. P. 819–825.

Sharer N., Schwarz M., Malone G. et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N. Engl. J. Med. 1998. Vol. 339. P. 645–652.

Singer M. V., Gyr K., Sarles H. Revised classification of pancreatitis. Gastroenterology. Report of the Second International Symposium on the classification of pancreatitis in Marseille. France. March 28–30, 1984. Vol. 1985. P. 683–685.

Slaff J., Jacobson D., Tillman C. R., Curington C., Toskes P. Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology. 1984. Vol. 87. P. 44–52.

Steer M. L., Waxman I., Freedman S. Chronic pancreatitis. N. Engl. J. Med. 1995. Vol. 332. P. 1482–1490.

Stevens T. Role of endoscopic ultrasonography in the diagnosis of acute and chronic pancreatitis. Gastrointest. Endosc. Clin. N. Am. 2013. Vol. 23. P. 735–747.

Stevens T., Conwell D. L., Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am. J. Gastroenterol. 2004. Vol. 99. P. 2256–2270.

Takeyama Y. Long-term prognosis of acute pancreatitis in Japan. Clin. Gastroenterol. Hepatol. 2009. Vol. 7. Р. S15–S17.

Talamini G., Falconi M., Bassi C. et al. Incidence of cancer in the course of chronic pancreatitis. Am. J. Gastroenterol. 1999. Vol. 94. P. 1253–1260.

Talar-Wojnarowska R., Wozniak B., Pazurek M., Malecka-Panas E. Outcome of pseudocysts complicating chronic pancreatitis. Hepatogastroenterology. 2010. Vol. 57. P. 631–634.

Taylor J. R., Gardner T. B., Waljee A. K., DiMagno M. J., Schoenfeld P. S. Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency. Aliment. Pharmacol. Ther. 2010. Vol. 31. P. 57–72.

Tirkes T., Fogel E. L., Sherman S. et al. Detection of exocrine dysfunction by MRI in patients with early chronic pancreatitis. Abdom. Radiol. 2017. Vol. 42. P. 544–551.

Trikudanathan G., Vega-Peralta J., Malli A. et al. Diagnostic performance of endoscopic ultrasound (EUS) for non-calcific chronic pancreatitis (NCCP) based on histopathology. Am. J. Gastroenterol. 2016. Vol. 111. P. 568–574.

Uc A., Andersen D. K., Bellin M. D. et al. Chronic pancreatitis in the 21st century — research challenges and opportunities: summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Pancreas. 2016. Vol. 45. P. 1365–1375.

Van den Bossche J., Laoui D., Morias Y. et al. Claudin-1, claudin-2 and claudin-11 genes differentially associate with distinct types of anti-inflammatory macrophages in vitro and with parasite- and tumour-elicited macrophages in vivo. Scand. J. Immunol. 2012. Vol. 75. P. 588–598.

van Dijk-van Aalst K., Van Den Driessche M., van Der Schoor S. et al. 13C mixed triglyceride breath test: a noninvasive method to assess lipase activity in children. J. Pediatr. Gastroenterol. Nutr. 2001. Vol. 32. P. 579–585.

Van Laetham J. L., Deviere J., Resibois A. et al. Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology. 1995. Vol. 108. P. 1873–1881.

Varadarajulu S., Eltoum I., Tamhane A., Eloubeidi M. A. Histopathologic correlates of noncalcific chronic pancreatitis by EUS: a prospective tissue characterization study. Gastrointest. Endosc. 2007. Vol. 66. P. 501–509.

Ventafridda V., Tamburini M., Caraceni A., De Сonno F., Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 1987. Vol. 59. P. 850–856.

Vitale G. C., Davis B. R., Zavaleta C., Vitale M., Fullerton J. K. Endoscopic retrograde cholangiopancreatography and histopathology correlation for chronic pancreatitis. Am. Surg. 2009. Vol. 75. P. 649–653.

Vogelmann R., Ruf D., Wagner M. et al. Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-P1 transgenic mouse model. Am. J. Phys. 2001. Vol. 280. P. G164–G172.

Vonlaufen A., Phillips P. A., Xu Z. et al. Withdrawal of alcohol promotes regression while continued alcohol intake promotes persistence of LPS-induced pancreatic injury in alcohol-fed rats. Gut. 2011. Vol. 60. P. 238–246.

Vonlaufen A., Xu Z., Daniel B. et al. Bacterial endotoxin: a trigger factor for alcoholic pancreatitis? Evidence from a novel, physiologically relevant animal model. Gastroenterology. 2007. Vol. 133. P. 1293–1303.

Wahoff D. C., Papalois B. E., Najarian J. S. et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann. Surg. 1995. Vol. 222. P. 562–575.

Walkowiak J., Herzig K. H., Strzykala K., Przyslawski J., Krawczynski M. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics. 2002. Vol. 110. Р. e7.

Wallace M. B., Hawes R. H., Durkalski V. et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest. Endosc. 2001. Vol. 53. P. 294–299.

Wang L. W., Li Z. S., Li S. D., Jin Z. D., Zou D. W., Chen F. Prevalence and clinical features of chronic pancreatitis in China: a retrospective multicenter analysis over 10 years. Pancreas. 2009. Vol. 38. P. 248–254.

Warshaw A. L., Richter J. M., Schapiro R. H. The cause and treatment of pancreatitis associated with pancreas divisum. Ann. Surg. 1983. Vol. 198. Р. 443–452.

Whitcomb D. C., Gorry M. C., Preston R. A. et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 1996. Vol. 14. P. 141–145.

Whitcomb D. C., Larusch J., Krasinskas A. M. et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat. Genet. 2012. Vol. 44. P. 1349–1354.

Whitcomb D. C., Preston R. A., Aston C. E. et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology. 1996. Vol. 110. P. 1975–1980.

Wiersema M. J., Wiersema L. M. Endosonography of the pancreas: normal variation versus changes of early chronic pancreatitis. Gastrointest. Endosc. Clin. N. Am. 1995. Vol. 5. P. 487–496.

Wu B. U., Pandol S. J., Liu I. L. Simvastatin is associated with reduced risk of acute pancreatitis: findings from a regional integrated healthcare system. Gut. 2015. Vol. 64. P. 133–138.

Xue J., Sharma V., Hsieh M. H. et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat. Commun. 2015. Vol. 6. P. 7158.

Xue J., Zhao Q., Sharma V. et al. Aryl hydrocarbon receptor ligands in cigarette smoke induce production of interleukin-22 to promote pancreatic fibrosis in models of chronic pancreatitis. Gastroenterology. 2016. Vol. 151. P. 1206–1217.

Yadav D., Eigenbrodt M. L., Briggs M. J., Williams D. K., Wiseman E. J. Pancreatitis: prevalence and risk factors among male veterans in a detoxification program. Pancreas. 2007. Vol. 34. P. 390–398.

Yadav D., O’Connell M., Papachristou G. I. Natural history following the first attack of acute pancreatitis. Am. J. Gastroenterol. 2012. Vol. 107. P. 1096–1103.

Yadav D., Timmons L., Benson J. T., Dierkhising R. A., Chari S. T. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am. J. Gastroenterol. 2011. Vol. 106. P. 2192–2199.

Yasuda M., Ito T., Oono T. et al. Fractalkine and TGF-P1 levels reflect the severity of chronic pancreatitis in humans. World J. Gastroenterol. 2008. Vol. 14. P. 6488–6495.

Yuan J., Lugea A., Zheng L. et al. Protein kinase D1 mediates NF-kappaB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2008. Vol. 295. P. G1190–G1201.

Yusoff I. F., Sahai A. V. A prospective, quantitative assessment of the effect of ethanol and other variables on the endosonographic appearance of the pancreas. Clin. Gastroenterol. Hepatol. 2004. Vol. 2. P. 405–409.

Zaninovic V., Gukovskaya A. S., Gukovsky I., Mouria M., Pandol S. J. Cerulein upregulates ICAM-1 in pancreatic acinar cells, which mediates neutrophil adhesion to these cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000. Vol. 279. P. G666-G676.